Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC90666 Bequinostatin C

    一种萘醌和GSTP1抑制剂。

  3. GC90665 Bequinostatin A

    一种萘醌和GSTP1抑制剂。

  4. GC90657 COMC

    2-Crotonyloxymethyl-2-cyclohexenone

    一种抗癌药物。

  5. GC90655 Lentztrehalose B

    一种具有多种生物活性的双糖微生物代谢产物。

  6. GC90640 SAAP 148 (trifluoroacetate salt)

    Synthetic Antimicrobial and Antibiofilm Peptide 148

    一种抗微生物肽。

  7. GC90631 LL-37 (human) (scrambled) (trifluoroacetate salt)

    Cathelicidin, CAP-18, FALL-39, hCAP-18

    LL-37(人类)的阴性对照。

  8. GC90630 CRAMP (140-173) (mouse) (trifluoroacetate salt)

    Cathelicidin-related Antimicrobial Peptide, Cathelin-related Antimicrobial Peptide, mCRAMP

    一种抗微生物肽。

  9. GC90622 Carbaethopendecine (bromide)

    Mucoseptonex

    一种含有季铵盐的阳离子表面活性剂,具有抗生素活性。

  10. GC90602 Tat (2-4) (trifluoroacetate salt)

    Transactivator of Transcription Peptide (2-4)

    一个肽。

  11. GC90598 DOG-IM4

    一种可离子化的阳离子脂质

  12. GC90582 Perfluorooctanesulfonic Acid

    Heptadecafluorooctanesulfonic Acid, Perfluorooctane sulfonate, Perfluorooctylsulfonic Acid, PFOS

    一种全氟烷基物质

  13. GC90579 Phenylglycine

    2-Phenylglycine, α-Phenylglycine, DL-Phenylglycine, NSC 7928, NSC 24619, NSC 32070

    一个建筑模块

  14. GC90564 LAP (trifluoroacetate salt)

    La Peptide, Lupus Autoantigen Peptide

    一种抗病毒肽。

  15. GC90562 Interleukin-8 (54-72) (human) (scrambled) (trifluoroacetate salt)

    C-X-C Motif Chemokine Ligand (54-72), CXCL8 (54-72), IL-8 (54-72)

    一种针对人类IL-8(54-72)的阴性对照。

  16. GC90554 E70K (trifluoroacetate salt)

    一种CXCL8-GAG相互作用的肽抑制剂

  17. GC90549 5-Aminoimidazole-4-carboxamide (hydrate)

    AIC

    一种合成前体

  18. GC90544 Magainin 2 (trifluoroacetate salt)

    MG2

    一种抗微生物阳离子肽。

  19. GC90533 (-)-Pinoresinol

    一种具有多种生物活性的木脂素

  20. GC90532 UFP101 (trifluoroacetate salt)

    一种合成肽和痛觉受体拮抗剂。

  21. GC90526 st-Ht31 (ammonium salt)

    sHt31

    一种可穿透细胞的硬脂酰化肽。

  22. GC90516 VK-II-86

    SOICR的抑制剂。

  23. GC90508 Ala-D-γ-Glu-Lys-D-Ala-D-Ala (trifluoroacetate salt)

    A0910, Ala-D-isoGlu-Lys-D-Ala-D-Ala

    一种肽聚糖五肽。

  24. GC90496 β-Cortolone

    20β-Cortolone, NSC 56997

    一种皮质醇的代谢产物。

  25. GC90490 PMX-53 (trifluoroacetate salt)

    AcF-OPdChaWR, AcPhe-Orn-Pro-D-Cyclohexylalanine-Trp-Arg, 3D53

    一种C5a受体拮抗剂

  26. GC90489 AC 187 (trifluoroacetate salt)

    Acetyl-(Asn30,Tyr32)-Calcitonin8-32, Acetyl-Asn30,Tyr32Salmon Calcitonin (8 -37), Acetyl-Asn30,Tyr32 sCT(8 -37)

    一种钙降素和淀粉样蛋白受体的拮抗剂。

  27. GC90488 Tat-Beclin 1 (acetate)

    Tat-BECN1

    一种诱导自噬的肽。

  28. GC90483 Magainin 1 (trifluoroacetate salt)

    MG1

    一种抗微生物阳离子肽。

  29. GC90363 10(11)-Cl-BBQ

    一种作为AhR激动剂的混合物。

  30. GC90243 Myelin Basic Protein (human, bovine, rat) (trifluoroacetate salt)

    MBP

    一种能引起脑炎的肽。

  31. GC90195 Posaconazole-d5

    POS-d5

    一种用于量化泊沙康唑的内部标准。

  32. GC90077 Furin Inhibitor I (trifluoroacetate salt)

    Decanoyl-Arg-Val-Lys-Arg-CMK

    一种前蛋白酶转化酶抑制剂

  33. GC90076 HA-14-1

    一种Bcl-2抑制剂

  34. GC90030 Demethoxycurcumin

    DMC

    天然的姜黄素在癌症和炎症中扮演重要角色。

  35. GC90022 (±)-Norepinephrine-d6 (hydrochloride)

    (±)-Arterenol-d6, DL-Noradrenaline-d6, (±)-Noradrenaline-d6, DL-Norepinephrine-d6

    一种用于量化去甲肾上腺素的内部标准

  36. GC26097 Zymosan A from Saccharomyces cerevisiae

    A zymosans; Zymosan A; Zymosan type A

    又称酵母多糖。淡灰色粉末,几乎不溶于水,但可在水中分散成均一的悬浮液。是从酵母细胞壁或酵母细胞提取的一种富含葡萄糖甘露糖的多糖。

  37. GC70170 Zilucoplan

    RA101495

    Zilucoplan (RA101495) 是一种 15 个氨基酸的大环肽,是一种有效的补体成分 5 (C5) 抑制剂。Zilucoplan 可用于免疫介导的坏死性肌病 (IMNM) 研究。
  38. GC70154 Yakuchinone A Yakuchinone A 是一种可以从 Alpinia oxyphylla 果实分离得到的天然产物,可以诱导细胞凋亡 (apoptosis),具有抗癌、抗炎活性。
  39. GC70120 Vixarelimab

    KPL-716

    Vixarelimab (KPL-716) 是一种人源的抗 oncostatin M (OSM)单克隆抗体,可以与 OSM 受体的β链结合,抑制 IL-31 和 OSM 的信号传导。Vixarelimab 可用于特应性皮炎和结节性痒疹等皮肤炎症性疾病研究。
  40. GC70119 Vipoglanstat

    BI 1029539; GS-248; OX-MPI

    Vipoglanstat (BI 1029539),甲酰胺,是一种有效的,选择性的,非肽人前列腺素 E 合成酶 1 (mPGES-1) 小分子抑制剂,具有口服活性。Vipoglanstat 也具有抗炎活性。
  41. GC70116 Vesencumab

    MNRP-1685A

    Vesencumab (MNRP-1685A) 是针对 neuropilin-1 (NRP-1) 的 IG1 抗体。Vesencumab 与 NRP-1 结合并阻止 NRP-1 与 VEGFR-2 偶联。Vesencumab 具有抗血管生成和抗肿瘤活性。Vesencumab可用于转移性实体瘤的研究,包括卵巢癌。
  42. GC70045 Tozorakimab

    MEDI-3506

    Tozorakimab (MEDI-3506) 是一种靶向白介素-33 (interleukin-33) 的人免疫球蛋白 G1 单克隆抗体。Tozorakimab 可用于研究慢性阻塞性肺疾病。
  43. GC70042 Tomaralimab

    OPN-305

    Tomaralimab (OPN-305) 是一种人源化的抗-TLR2 (anti-TLR2) IgG4 单克隆抗体。Tomaralimab 具有研究骨髓增生异常综合征 (MDS) 的潜力。
  44. GC70038 TMX-201 TMX-201 是一种 TLR7 配体-磷脂共轭物。TMX-201 显示出有效的的免疫刺激活性。TMX-201 可用于乳腺癌和黑色素瘤的研究。
  45. GC70036 TLR9-IN-1 TLR9-IN-1 是一种有效且选择性的 TLR9 抑制剂,对人 TLR9 的 IC50 为 7 nM。TLR9-IN-1可用于研究不良免疫应答相关疾病。
  46. GC70035 TLR7/8 agonist 1 TLR7/8 agonist 1是一种 toll 样受体 (TLR7)/TLR8 的双重激动剂。
  47. GC70034 TL8-506 TL8-506 是一种特异性 TLR8 激动剂,EC50 为 30 nM。TL8-506 可用于结核病和自身免疫性疾病的研究。
  48. GC70026 Thymidine 3',5'-diphosphate tetrasodium

    Deoxythymidine 3′,5′-diphosphate tetrasodium; pdTp tetrasodium

    Thymidine 3',5'-diphosphate (Deoxythymidine 3′,5′-diphosphate) tetrasodium 是葡萄球菌核酸酶和含有 1 的都铎结构域 (SND1,MicroRNA 调控复合体 RISC 亚基) 与 [3,5-2H2] 酪氨酸核酸酶 ( [3,5-2H2] tyrosyl nuclease) 的选择性抑制剂。Thymidine 3',5'-diphosphate tetrasodium 具有抗肿瘤活性,在生化反应也可用作催化剂。
  49. GC70017 Tesidolumab

    LFG316; Anti-Human C5 Recombinant Antibody

    Tesidolumab (LFG316) 是一种全人IgG1/Λ抗c5单克隆抗体,分子量为143 kDa(不含糖基化)。Tesidolumab (LFG316)阻断C5的切割,防止膜攻击复合体的后续形成。
  50. GC70004 Tebentafusp

    IMCgp100

    Tebentafusp (IMCgp100) 是一种双特异性融合蛋白,靶向 gp100 (一种黑色素瘤相关抗原)。Tebentafusp 通过高亲和力 T 细胞受体 (TCR) 结合域和抗 CD3 T 细胞接合域引导 T 细胞杀死表达 gp100 的肿瘤细胞。Tebentafusp 诱导炎性细胞因子和细胞溶解蛋白的产生,导致肿瘤细胞的直接裂解。
  51. GC69998 TBK1-IN-1 TBK1-IN-1 是一种有效的选择性 TANK 结合激酶 1 (TBK1) 抑制剂,IC50 值为 22.4 nM。TBK1-IN-1 抑制 TBK1 下游靶基因 cxcl10 和 ifnβ 的表达。TBK1-IN-1 具有抗癌活性。

Items 551 to 600 of 4267 total

per page

Set Descending Direction